[May 26, 2016]

Global Relapsed Acute Myeloid Leukemia Pipeline Report 2016 - Review of 52 Companies & Drug Profiles - Research and Markets

Research and Markets has announced the addition of the "Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Relapsed Acute Myeloid Leukemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Relapsed Acute Myeloid Leukemia and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

1. Introduction
2. Relapsed Acute Myeloid Leukemia Overview
3. Therapeutics Development
4. Pipeline Products for Relapsed Acute Myeloid Leukemia - Overview
5. Pipeline Products for Relapsed Acute Myeloid eukemia - Comparative Analysis
6. Relapsed Acute Myeloid Leukemia - Therapeutics under Development by Companies
7. Relapsed Acute Myeloid Leukemia - Therapeutics under Investigation by Universities/Institutes
8. Relapsed Acute Myeloid Leukemia Products Glance
9. Late Stage Products
10. Clinical Stage Products
11. Early Stage Products
12. Relapsed Acute Myeloid Leukemia - Products under Development by Companies
13. Relapsed Acute Myeloid Leukemia - Products under Investigation by Universities/Institutes
14. Relapsed Acute Myeloid Leukemia - Companies Involved in Therapeutics Development

• 4SC AG
• AbbVie Inc.
• Actinium Pharmaceuticals, Inc.
• Agios Pharmaceuticals, Inc.
• Amgen Inc.
• Arog Pharmaceuticals, Inc.
• Array BioPharma Inc.
• Astellas Pharma Inc.
• AVEO Pharmaceuticals, Inc.
• Bellicum Pharmaceuticals, Inc.
• BioLineRx, Ltd.
• BioSight Ltd.
• Boehringer Ingelheim GmbH
• Boston Biomedical, Inc.
• Bristol-Myers Squibb Company
• Calithera Biosciences, Inc.
• Celgene Corporation
• Cellceutix Corporation
• Cornerstone Pharmaceuticals, Inc.
• CTI (News - Alert) BioPharma Corp.
• Daiichi Sankyo Company, Limited
• Eisai Co., Ltd.
• EpiZyme, Inc.
• Exelixis, Inc.
• F. Hoffmann-La Roche Ltd.
• FORMA Therapeutics, Inc.
• Fujifilm Corporation
• GlaxoSmithKline Plc
• GlycoMimetics, Inc.
• Igenica Biotherapeutics, Inc.
• Incyte Corporation
• Jiangsu Hansoh Pharmaceutical Co., Ltd.
• Johnson & Johnson
• JW Pharmaceutical Corporation
• Karyopharm Therapeutics, Inc.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160526005852/en/

[ Back To TMCnet.com's Homepage ]